Crafting a Robust Australian-Specific Annexure (ASA) for Risk Management Plans: A Comprehensive Guide
In the complex landscape of pharmaceutical regulations, it is paramount to prioritise the safety and efficacy of medicinal products. For sponsors aiming to introduce their products to the Australian market, navigating the Therapeutic Goods Administration (TGA) requirements is a crucial step. A pivotal aspect of this process, specifically for medicinal products (not applicable to medical…
